Intramedullary Application of Local Antibiotic Bullets for the Treatment of Long Bone Fracture Related Infection
Overview
Affiliations
Purpose: The optimal means of local antibiotic delivery for fracture related infection is unknown. Until now, intramedullary application of calcium sulphate based local antibiotics has been challenging. We report on the use of a newly available mode of preparation and delivery: the Stimulan Bullet Mat and Introducer (Biocomposites Ltd, Staffordshire, England).
Methods: A retrospective analysis of prospectively collected data for infection cases at two separate tertiary referral institutions was performed. We included cases of long bone FRI with a retained intramedullary nail, treated with a single stage protocol of metalwork removal, debridement, local antibiotic application using the novel mould and applicator, with additional bony stabilisation and soft tissue reconstruction where required.
Results: All 13 patients achieved infection remission rate with an average follow-up of 19.7 months (range 12-28). All 6 patients with infection around an unhealed fracture achieved union at an average 8 months (range 4-12) from debridement. No patients developed aseptic wound leak.
Conclusions: Antibiotic impregnated calcium sulphate can be used safely as part of a single stage treatment protocol for the treatment of long bone fracture related infection following intramedullary nailing. We have demonstrated high rates of infection remission and union, using a newly available intramedullary applicator.
Evans A, Kimmel M, Kharbat A, Shakir H J Surg Case Rep. 2024; 2024(7):rjae468.
PMID: 39044778 PMC: 11264129. DOI: 10.1093/jscr/rjae468.
Microbiological Profile of Fracture Related Infection at a UK Major Trauma Centre.
Patel K, Gill L, Tissingh E, Galanis A, Hadjihannas I, Iliadis A Antibiotics (Basel). 2023; 12(9).
PMID: 37760655 PMC: 10525273. DOI: 10.3390/antibiotics12091358.
Current Concepts of Fracture-Related Infection.
He S, Yu B, Jiang N Int J Clin Pract. 2023; 2023:4839701.
PMID: 37153693 PMC: 10154639. DOI: 10.1155/2023/4839701.
Jacob C, Daw J, Santiago-Torres J J Bone Jt Infect. 2023; 8(2):91-97.
PMID: 37123503 PMC: 10134749. DOI: 10.5194/jbji-8-91-2023.
Sliepen J, Corrigan R, Dudareva M, Wouthuyzen-Bakker M, Rentenaar R, Atkins B Antibiotics (Basel). 2022; 11(10).
PMID: 36289989 PMC: 9598690. DOI: 10.3390/antibiotics11101330.